Abelacimab for Prevention of Venous Thromboembolism. Reply

N Engl J Med. 2021 Nov 4;385(19):1822-1823. doi: 10.1056/NEJMc2114895.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Humans
  • Risk Factors
  • Venous Thromboembolism* / prevention & control

Substances

  • Anticoagulants